Moleculin Biotech, Inc. Other Non-Current Liabilities
Moleculin Biotech, Inc. (MBRX) had Other Non-Current Liabilities of $50.00 thousand as of 2016-09-30, per its 10-Q filed 2016-11-21.
Discontinued › Balance Sheet › Liabilities › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:OtherLiabilitiesNoncurrent · last filed 2016-11-21
- 2016-09-30: Other Liabilities, Noncurrent $50.00K.
- 2016-06-30: Other Liabilities, Noncurrent $0.00; Other Liabilities, Noncurrent as first filed $600.00K.
- 2015-12-31: Other Liabilities, Noncurrent $0.00.
| Period end | Other Liabilities, Noncurrent | Other Liabilities, Noncurrent as first filed |
|---|---|---|
| 2016-09-30 | $50.00K 10-Q · filed 2016-11-21 | |
| 2016-06-30 | $0.00 10-Q · filed 2016-11-21 | $600.00K 10-Q · filed 2016-08-15 |
| 2015-12-31 | $0.00 10-Q · filed 2016-11-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |